The urgency and global nature of the COVID-19 pandemic has resulted in health research being undertaken at an unprecedented scale. This has been accompanied by a race to disseminate, share and publish data and findings, which in turn has led to retractions, questionable peer review, and pre-publication peer review via twitter, resulting in confusion amongst researchers, regulators, and the public. What has this meant for credibility of science and trust in the scientific enterprise? What are the real costs here? How can publishing models accommodate our need for urgency, research integrity and trustworthiness when they're needed most?
Chair: Professor Ross Upshur, Head, Division of Clinical Public Health at the Dalla Lana School of Public Health, Toronto, Canada
Dr Ezekiel J. Emanuel, Professor of Health Care Management and Professor of Medical Ethics and Health Policy in the Perelman School of Medicine
Dr Laragh Gollogly – Editor, Bulletin of the World Health Organization and member of the International Committee of Medical Journal Ethics